Company
Canon
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
131
510(k), De Novo and PMA
Device trials
1
As lead sponsor, any status
Adverse event reports
21
Received Nov 1, 2025 to Nov 20, 2026
Recall records
57
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
CAJPY
OTC · CANON INC
Public float
Unknown
Not reported in US filings
Revenue
Not reported
Net income
Not reported
R&D spending
Not reported
Cash
Not reported
Long-term debt
Not reported
Shares outstanding
Not reported
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Canon.
Latest FDA decisions
The 8 newest of 131 since 2015.
K263648 · Decided Oct 29, 2026 · 27 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
K260324 · Decided May 22, 2026 · 112 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
K253596 · Decided May 20, 2026 · 183 days after receipt
Device type: System, X-Ray, Tomography, Computed (JAK) · Radiology & Imaging
128 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT04024748 · 24 participants · Start Oct 22, 2019 · Primary completion Nov 26, 2019
Device: PET/CT imaging · For: Cancer Patients
Sites: Henderson, Nevada
Reports received
21
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
9
43% of reports
Injury reports
11
52% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 1 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 1 | 1 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 1 | 0 | 0 |
| Jun 24 | 0 | 0 | 1 | 0 |
| Jul 24 | 1 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 2 | 0 | 0 |
| Oct 24 | 3 | 3 | 0 | 0 |
| Nov 24 | 0 | 2 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 0 | 1 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 0 | 1 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 1 | 1 | 0 | 0 |
| Sep 25 | 1 | 0 | 1 | 0 |
| Oct 25 | 1 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 3 | 1 | 0 | 0 |
| Jan 26 | 1 | 2 | 0 | 0 |
| Feb 26 | 0 | 2 | 0 | 0 |
| Mar 26 | 0 | 2 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 2 | 0 | 0 | 0 |
| Jun 26 | 1 | 1 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 1 | 1 | 0 | 0 |
| Sep 26 | 0 | 1 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
1 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- CANON13
5 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000COpen, Classified
Z-0289-2027 · Started Oct 12, 2026 · Posted by FDA Oct 27, 2026
Reason given: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.
Cause as FDA categorized it: Software design · Device type: Interventional Fluoroscopic X-Ray System (OWB)
- ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000FOpen, Classified
Z-0290-2027 · Started Oct 12, 2026 · Posted by FDA Oct 27, 2026
Reason given: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.
Cause as FDA categorized it: Software design · Device type: Interventional Fluoroscopic X-Ray System (OWB)
- ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000VOpen, Classified
Z-0291-2027 · Started Oct 12, 2026 · Posted by FDA Oct 27, 2026
Reason given: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.
Cause as FDA categorized it: Software design · Device type: Interventional Fluoroscopic X-Ray System (OWB)
54 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.